CLCidnee Luu

Cidnee Luu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cidnee Luu has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Kilohertz Transcranial Magnetic Perturbation (kTMP) for Upper Extremity Motor Recovery After Stroke: A Nonrandomized Pilot Trial

    by Christina M Merrick, Feiyang Dai, Saumya Singh, Ian O’KIdhain, Philipp Reber, Cidnee Luu, Angel V Peterchev, Daniel Sheltraw, Richard B Ivry, Ludovica Labruna, et al.

    Structured Importance: Upper extremity impairment is a leading cause of post-stroke disability, yet clinically approved neuromodulation therapies are currently limited by the risks and costs of surgical implantation. There is an unmet need for non-invasive brain stimulation. Objective: To evaluate the feasibility, safety, and preliminary clinical efficacy of a novel form of non-invasive brain stimulation, kilohertz transcranial magnetic perturbation (kTMP), for upper limb motor recovery after stroke. Design: A single-center, open-label trial was conducted between September 2025 and April 2026 and comprised a 4-week standard-of-care baseline period, 4 weeks of active treatment with kTMP combined with motor training, and a 4-week follow-up. Setting: Academic research center. Participants: Seven individuals with chronic stroke and upper extremity motor deficits. Intervention: Four weeks of kTMP (3 sessions/week), a brain stimulation approach using magnetic induction to generate subthreshold electric fields, paired with motor tasks. Main Outcomes: Change in Fugl-Meyer Assessment for Upper Extremity (FMA-UE) scores across study periods (standard-of-care baseline, active treatment, follow up). Secondary outcomes included measures of movement smoothness (Spectral Arc Length, SPARC) and fragmentation (mean velocity peak count), and intervention tolerability ratings. Results: Across 7 participants (mean [SD] age, 57.4 [8.7] years; 4 males; mean [SD] time poststroke, 3.5 [2.1] years). No device-related adverse events occurred, and the intervention was well-tolerated (participants rated sensation intensity at an average of less than 0.5 on a 0-10 scale). FMA-UE scores remained stable during the baseline period (mean change, +0.14 points; 95% CI, –1.21 to 1.50; adjusted P =.98), increased significantly following the kTMP-intervention (mean change, +7.00 points; 95% CI, 5.31 to 8.69; adjusted P =.047), and were sustained at the 4-week follow-up (mean change, –1.33 points; 95% CI, –2.42 to –0.25; adjusted P =.13). Movement smoothness improved significantly within 1 week of kTMP onset (mean change, 1.48 points; 95% CI, 0.49–2.47; adjusted P =.03); movement fragmentation showed a similar but nonsignificant trend. Conclusions and Relevance: This pilot trial provides preliminary evidence that kTMP combined with motor tasks is safe, feasible, and may support upper extremity recovery. These pilot data warrant large, randomized controlled trials to evaluate efficacy in support of poststroke motor recovery. Trial Registration: ClinicalTrials.gov Identifier: NCT06317194 Key Points: Question: Is kilohertz transcranial magnetic perturbation (kTMP) a safe, feasible, and effective non-invasive intervention for improving upper extremity motor recovery in chronic stroke? Findings: In this single-center, open-label pilot trial of 7 participants with chronic stroke, upper extremity motor impairment (FMA-UE) remained stable during a 4-week baseline period and significantly improved (mean change, +7.0 points) following 4 weeks of active kTMP treatment combined with motor tasks, with gains sustained at 4-week follow-up. No device-related adverse events occurred. Meaning: These preliminary findings suggest that kTMP is safe and feasible and may support upper extremity motor recovery after stroke, warranting further evaluation.

  • Open Access

    A systematic assessment of safety, tolerability and blinding effectiveness of kilohertz transcranial magnetic perturbation (kTMP)

    by Christina M Merrick, Guy Avraham, Philipp Reber, Katheryn Thayer-Pham, Feiyang Dai, Saumya Singh, Cidnee Luu, Ian O’KIdhain, Haajar Ahmad-Ali, Angel V Peterchev, et al.

    Objective. Non-invasive brain stimulation (NIBS) techniques are increasingly used to modulate brain activity in basic and translational research. Kilohertz transcranial magnetic perturbation (kTMP) is a recently developed NIBS approach that uses magnetic induction to generate subthreshold electric fields in the brain. kTMP has been shown to modulate cortical excitability while producing no perceptible sensation at the stimulation site. However, its safety and tolerability have not yet been systematically evaluated—a gap this study aims to address. Approach. We conducted sham-controlled experiments, within-subject comparisons, and patient feasibility studies with kTMP, entailing 433 sessions across 143 individuals. Participants rated annoyance, muscle activation, and pain on a 0–10 scale after each session. With primary motor cortex (M1) as the target, we compared active stimulation (∼8 V m −1 cortical field) to sham (0 V m −1 ) in healthy adults and chronic stroke patients. In healthy adults, we compared active vs. sham stimulation applied to dorsolateral prefrontal cortex, superior temporal gyrus, and cerebellum. Additional datasets examined tolerability across active kTMP parameters and multi-session feasibility in stroke patients. Safety monitoring included continuous observation for abnormal motor activity and EMG recording in initial experiments. Main results. No device-related adverse reactions occurred across 433 sessions. EMG monitoring revealed no artifacts, and no participants exhibited involuntary muscle contractions or signs of abnormal cortical excitation. kTMP was well tolerated, with mean ratings for active and sham stimulation remaining below 1.5 (where ‘2’ indicates just-noticeable sensation). Permutation tests showed no significant active–sham differences and bootstrapped 95% confidence intervals consistently fell within the ±1 equivalence margin. When auditory masking was used, participants could not distinguish active from sham stimulation. Significance. kTMP achieves cortical E-fields an order of magnitude higher than conventional subthreshold tES while maintaining robust safety margins and tolerability indistinguishable from sham, supporting its use for rigorous double-blind studies and translational settings. Trial Registration: ClinicalTrials.gov Identifier: NCT06317194.


  • Correlating Motion Artifacts in Wet and Dry Electrodes With Head Kinematics During Physical Activities in Ambulatory EEG Monitoring

    by Cidnee Luu, Yuan Gao, Han Cat Nguyen, Saeid Soltanian, Naznin Virji-Babul, Peyman Servati, H. F. Machiel Van Der Loos, Lyndia C. Wu

    Electroencephalography (EEG) is a common neuroimaging technique used in clinical, research, and consumer technology given its noninvasiveness, high temporal resolution, and sensitivity. The main challenge in ambulatory EEG monitoring is the presence of substantial motion artifacts, especially for high-intensity movements such as running. This study compared motion artifacts in gold-cup, gel, and dry electrodes during different levels of physical activity. Eight healthy participants were instrumented with a wearable EEG cap and an instrumented mouthguard to measure head kinematics. While all electrode types performed similarly in the resting state, dry electrodes showed high-amplitude motion artifacts and worse performance during walking, running, and jumping. EEG-motion coherence was found to be higher for dry electrodes in low-intensity movements (e.g., walking with 0.1–0.5-g head acceleration, where 1 g =9.81 m/s $^{2}$ ), but similar across the three electrode types for medium-to-high-intensity movements (e.g., running and jumping with 0.5–3.5-g head acceleration), with peak coherences at up to 20 Hz. Fast walk trials showed the highest linear correlation between EEG signal and head acceleration, indicating potentially better coupling between the head and the electrode at this movement intensity. Our results imply that dry electrodes require further hardware development to mitigate motion artifacts before reliable application in ambulatory monitoring, and wet electrodes also exhibit clear movement-related artifacts in higher intensity movements. Uniquely, we identified EEG-motion coupling as a contributing factor to motion artifact characteristics, and coherence analysis may be a promising approach for motion artifact identification and quantification. Further characterization, quantification, and mitigation of motion artifacts will aid in higher quality measurement and meaningful interpretation of ambulatory EEG signals for clinical and research applications.


  • Open Access

    Resting State EEG Variability and Implications for Interpreting Clinical Effect Sizes

    by Eric Liu, Cidnee Luu, Lyndia C. Wu

    Resting state electroencephalography (rsEEG) is widely used to investigate intrinsic brain activity, with the potential for detecting neurophysiological abnormalities in clinical conditions from neurodegenerative disease to developmental disorders. When interpreting quantitative rsEEG changes, a key question is: how much deviation from a healthy normal brain state indicates a clinically significant change? Here, we build on the existing rsEEG variability literature by quantifying how this baseline rsEEG range can be attributed to common but underinvestigated sources of variability: experiment day, time of day, and pre-recording exercise level. We found that even within individuals, frequency band powers and entropy measures can vary by 7% (sample entropy and relative alpha power) to 28% (absolute delta power). Absolute and relative delta power increased significantly after running, while relative theta power decreased significantly. Relative beta and gamma power were significantly higher in the afternoon compared to morning trials. Sample entropy and alpha power were relatively consistent. The coefficients of variability we found are similar to some clinical rsEEG effect sizes identified in prior literature, bringing into question the clinical significance of these effect sizes. Furthermore, time of day and activity level accounted for more rsEEG variability than experiment day, indicating the potential to reduce variability by controlling for these factors in repeated-measures studies.